NCT03135574View on ClinicalTrials.gov

Prevalence of a High-intensity Signal of the Oculomotor Nerve on T2 MRI Sequence in Patients With Ophthalmoplegia

CompletedOBSERVATIONAL
Enrollment

148

Participants

Timeline

Start Date

April 16, 2017

Primary Completion Date

February 22, 2021

Study Completion Date

February 22, 2021

Conditions
Ophthalmoplegia
Interventions
DIAGNOSTIC_TEST

MRI T2 sequence of the oculomotor tract

Patients with ophthalmoplegia will benefit from an MRI T2 sequence of the oculomotor tract (additional time of 4 minutes).

Trial Locations (1)

75019

Fondation Ophtalmologique A. de Rothschild, Paris

All Listed Sponsors
lead

Fondation Ophtalmologique Adolphe de Rothschild

NETWORK

NCT03135574 - Prevalence of a High-intensity Signal of the Oculomotor Nerve on T2 MRI Sequence in Patients With Ophthalmoplegia | Biotech Hunter | Biotech Hunter